{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:48:34Z","timestamp":1794541714836,"version":"4.9.1"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41574-026-01261-w","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:30:36Z","timestamp":1780666236000},"page":"516-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-577X","authenticated-orcid":false,"given":"Helena J.","family":"Teede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Vanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi T.","family":"Piltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-1502","authenticated-orcid":false,"given":"Elisabet","family":"Stener-Victorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5772-6484","authenticated-orcid":false,"given":"Lisa J.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Bahri Khomami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"1261_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01072-3","volume":"16","author":"M Cai","year":"2023","unstructured":"Cai, M. et al. Past and present: a bibliometric study on polycystic ovary syndrome. J. Ovarian Res. 16, 42 (2023).","journal-title":"J. Ovarian Res."},{"key":"1261_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede, H., Deeks, A. & Moran, L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 8, 41 (2010).","journal-title":"BMC Med."},{"key":"1261_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede, H. J. et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 120, 767\u2013793 (2023).","journal-title":"Fertil. Steril."},{"key":"1261_CR4","doi-asserted-by":"publisher","unstructured":"Mousa, A., Tay, C. T. & Teede, H. J. Technical Report for the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome https:\/\/doi.org\/10.26180\/23625288 (Monash Univ., 2023).","DOI":"10.26180\/23625288"},{"key":"1261_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/jmwh.13706","volume":"70","author":"M Bahri Khomami","year":"2024","unstructured":"Bahri Khomami, M. Polycystic ovary syndrome as a key risk factor in pregnancy outcomes: a midwifery perspective from the international guideline. J. Midwifery Womens Health 70, 200\u2013203 (2024).","journal-title":"J. Midwifery Womens Health"},{"key":"1261_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.30549","volume":"7","author":"M Bahri Khomami","year":"2024","unstructured":"Bahri Khomami, M. & Teede, H. J. Addressing polycystic ovary syndrome in pregnancy care to improve outcomes. JAMA Netw. Open 7, e2430549 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1261_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(26)00717-8","author":"HJ Teede","year":"2026","unstructured":"Teede, H. J. et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(26)00717-8 (2026).","journal-title":"Lancet"},{"key":"1261_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103287","volume":"84","author":"HJ Teede","year":"2025","unstructured":"Teede, H. J. et al. Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey. EClinicalMedicine 84, 103287 (2025).","journal-title":"EClinicalMedicine"},{"key":"1261_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2026.1370","author":"T Piltonin","year":"2026","unstructured":"Piltonin, T., Kuusiniemi, E. & Teede, H. Pathological ovarian cysts and PCOS: a cross-sectional population-based cohort study. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2026.1370 (2026).","journal-title":"JAMA Intern. Med."},{"key":"1261_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102927","volume":"78","author":"HJ Teede","year":"2024","unstructured":"Teede, H. J. et al. International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women\u2019s health condition. EClinicalMedicine 78, 102927 (2024).","journal-title":"EClinicalMedicine"},{"key":"1261_CR11","unstructured":"National Institutes of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome https:\/\/prevention.nih.gov\/sites\/g\/files\/mnhszr241\/files\/2018-06\/FinalReport.pdf (NIH, 2012)."},{"key":"1261_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49749-1","volume":"15","author":"M Bahri Khomami","year":"2024","unstructured":"Bahri Khomami, M. et al. Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Nat. Commun. 15, 5591 (2024).","journal-title":"Nat. Commun."},{"key":"1261_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49752-6","volume":"15","author":"M Bahri Khomami","year":"2024","unstructured":"Bahri Khomami, M. et al. Systematic review and meta-analysis of birth outcomes in women with polycystic ovary syndrome. Nat. Commun. 15, 5592 (2024).","journal-title":"Nat. Commun."},{"key":"1261_CR14","first-page":"312","volume":"5","author":"AE Kim","year":"2024","unstructured":"Kim, A. E., Lee, I. T., Ottey, S. & Dokras, A. Lack of adequate counseling about pregnancy complications in patients with polycystic ovary syndrome: a cross-sectional survey study. F. S. Rep. 5, 312\u2013319 (2024).","journal-title":"F. S. Rep."},{"key":"1261_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/cen.14723","volume":"97","author":"M Bahri Khomami","year":"2022","unstructured":"Bahri Khomami, M. et al. Clinical management of pregnancy in women with polycystic ovary syndrome: an expert opinion. Clin. Endocrinol. 97, 227\u2013236 (2022).","journal-title":"Clin. Endocrinol."},{"key":"1261_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-0043-1777323","volume":"41","author":"RM Garad","year":"2023","unstructured":"Garad, R. M. et al. Breaking boundaries: toward consistent gender-sensitive language in sexual and reproductive health guidelines. Semin. Reprod. Med. 41, 5\u201311 (2023).","journal-title":"Semin. Reprod. Med."},{"key":"1261_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/01674820903477593","volume":"31","author":"L Moran","year":"2010","unstructured":"Moran, L., Gibson-Helm, M., Teede, H. & Deeks, A. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J. Psychosom. Obstet. Gynecol. 31, 24\u201331 (2010).","journal-title":"J. Psychosom. Obstet. Gynecol."},{"key":"1261_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tem.2018.08.005","volume":"29","author":"KA Walters","year":"2018","unstructured":"Walters, K. A. et al. New perspectives on the pathogenesis of PCOS: neuroendocrine origins. Trends Endocrinol. Metab. 29, 841\u2013852 (2018).","journal-title":"Trends Endocrinol. Metab."},{"key":"1261_CR19","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham, A. E. et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 10, 668\u2013680 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1261_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41574-021-00517-x","volume":"17","author":"E Stener-Victorin","year":"2021","unstructured":"Stener-Victorin, E. & Deng, Q. Epigenetic inheritance of polycystic ovary syndrome \u2014 challenges and opportunities for treatment. Nat. Rev. Endocrinol. 17, 521\u2013533 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1261_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day, F. et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 14, e1007813 (2018).","journal-title":"PLoS Genet."},{"key":"1261_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/humrep\/deab250","volume":"37","author":"JS Tyrmi","year":"2022","unstructured":"Tyrmi, J. S. et al. Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome. Hum. Reprod. 37, 352\u2013365 (2022).","journal-title":"Hum. Reprod."},{"key":"1261_CR23","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1038\/s41588-025-02393-x","volume":"57","author":"H Zhao","year":"2025","unstructured":"Zhao, H. et al. Multi-ancestry genome-wide association analyses of polycystic ovary syndrome. Nat. Genet. 57, 2669\u20132681 (2025).","journal-title":"Nat. Genet."},{"key":"1261_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas, M. & Dunaif, A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr. Rev. 43, 927\u2013965 (2022).","journal-title":"Endocr. Rev."},{"key":"1261_CR25","doi-asserted-by":"publisher","DOI":"10.1530\/REP-25-0126","volume":"170","author":"YV Louwers","year":"2025","unstructured":"Louwers, Y. V., Visser, J. A., Dunaif, A. & Laven, J. S. E. Polycystic ovary syndrome: origins and implications: genetics of polycystic ovary syndrome (PCOS). Reproduction 170, e250126 (2025).","journal-title":"Reproduction"},{"key":"1261_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/humrep\/deae066","volume":"39","author":"C Vatier","year":"2024","unstructured":"Vatier, C. & Christin-Maitre, S. Epigenetic\/circadian clocks and PCOS. Hum. Reprod. 39, 1167\u20131175 (2024).","journal-title":"Hum. Reprod."},{"key":"1261_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep22883","volume":"6","author":"M Kokosar","year":"2016","unstructured":"Kokosar, M. et al. Epigenetic and transcriptional alterations in human adipose tissue of polycystic ovary syndrome. Sci. Rep. 6, 22883 (2016).","journal-title":"Sci. Rep."},{"key":"1261_CR28","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1210\/jc.2018-00935","volume":"103","author":"E Nilsson","year":"2018","unstructured":"Nilsson, E. et al. Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 103, 4465\u20134477 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36706","volume":"10","author":"K Quan","year":"2024","unstructured":"Quan, K., Ning, S., You, Z. & Deng, G. Bioinformatics analysis of the role of RNA modification regulators in polycystic ovary syndrome. Heliyon 10, e36706 (2024).","journal-title":"Heliyon"},{"key":"1261_CR30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"Stepto, N. K. et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum. Reprod. 28, 777\u2013784 (2013).","journal-title":"Hum. Reprod."},{"key":"1261_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/humrep\/deu351","volume":"30","author":"M Maliqueo","year":"2015","unstructured":"Maliqueo, M. et al. Placental STAT3 signaling is activated in women with polycystic ovary syndrome. Hum. Reprod. 30, 692\u2013700 (2015).","journal-title":"Hum. Reprod."},{"key":"1261_CR32","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","volume":"24","author":"B Tata","year":"2018","unstructured":"Tata, B. et al. Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat. Med. 24, 834\u2013846 (2018).","journal-title":"Nat. Med."},{"key":"1261_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejogrb.2012.10.015","volume":"166","author":"M Maliqueo","year":"2013","unstructured":"Maliqueo, M. et al. Placental steroidogenesis in pregnant women with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 166, 151\u2013155 (2013).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1261_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/humupd\/dmz036","volume":"26","author":"MN Gunning","year":"2020","unstructured":"Gunning, M. N. et al. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis. Hum. Reprod. Update 26, 103\u2013117 (2020).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR35","doi-asserted-by":"publisher","first-page":"e3810","DOI":"10.1210\/clinem\/dgaf121","volume":"110","author":"A Kanina","year":"2025","unstructured":"Kanina, A. et al. Adverse cardiometabolic outcomes in men with sisters with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 110, e3810\u2013e3817 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S2040174417001118","volume":"9","author":"ES Barrett","year":"2018","unstructured":"Barrett, E. S. et al. Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure. J. Dev. Orig. Health Dis. 9, 307\u2013314 (2018).","journal-title":"J. Dev. Orig. Health Dis."},{"key":"1261_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni, N. E. H. et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 33, 513\u2013530 (2021).","journal-title":"Cell Metab."},{"key":"1261_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01183-9","volume":"11","author":"S Risal","year":"2021","unstructured":"Risal, S. et al. Prenatal androgen exposure causes a sexually dimorphic transgenerational increase in offspring susceptibility to anxiety disorders. Transl. Psychiatry 11, 45 (2021).","journal-title":"Transl. Psychiatry"},{"key":"1261_CR39","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","volume":"25","author":"S Risal","year":"2019","unstructured":"Risal, S. et al. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat. Med. 25, 1894\u20131904 (2019).","journal-title":"Nat. Med."},{"key":"1261_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40618-017-0728-5","volume":"41","author":"R Cannarella","year":"2018","unstructured":"Cannarella, R., Condorelli, R. A., Mongio\u00ec, L. M., La Vignera, S. & Calogero, A. E. Does a male polycystic ovarian syndrome equivalent exist? J. Endocrinol. Invest. 41, 49\u201357 (2018).","journal-title":"J. Endocrinol. Invest."},{"key":"1261_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1530\/EC-17-0218","volume":"6","author":"N Crisosto","year":"2017","unstructured":"Crisosto, N. et al. Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome. Endocr. Connect. 6, 607\u2013613 (2017).","journal-title":"Endocr. Connect."},{"key":"1261_CR42","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1210\/jc.2007-2256","volume":"93","author":"SE Recabarren","year":"2008","unstructured":"Recabarren, S. E. et al. Metabolic profile in sons of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 93, 1820\u20131826 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR43","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1210\/jc.2008-0255","volume":"93","author":"SE Recabarren","year":"2008","unstructured":"Recabarren, S. E. et al. Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood. J. Clin. Endocrinol. Metab. 93, 3318\u20133324 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.fertnstert.2016.03.029","volume":"106","author":"LC Torchen","year":"2016","unstructured":"Torchen, L. C. et al. Increased antim\u00fcllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertil. Steril. 106, 50\u201355 (2016).","journal-title":"Fertil. Steril."},{"key":"1261_CR45","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/humrep\/deu282","volume":"29","author":"DM Liu","year":"2014","unstructured":"Liu, D. M. et al. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Hum. Reprod. 29, 2764\u20132772 (2014).","journal-title":"Hum. Reprod."},{"key":"1261_CR46","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2337\/dc07-2190","volume":"31","author":"S Sam","year":"2008","unstructured":"Sam, S., Coviello, A. D., Sung, Y. A., Legro, R. S. & Dunaif, A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care 31, 1237\u20131241 (2008).","journal-title":"Diabetes Care"},{"key":"1261_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.metabol.2007.08.010","volume":"57","author":"S Sam","year":"2008","unstructured":"Sam, S., Sung, Y. A., Legro, R. S. & Dunaif, A. Evidence for pancreatic \u03b2-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism 57, 84\u201389 (2008).","journal-title":"Metabolism"},{"key":"1261_CR48","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1007\/s00125-007-0831-9","volume":"50","author":"JP Baillargeon","year":"2007","unstructured":"Baillargeon, J. P. & Carpentier, A. C. Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia 50, 2424\u20132432 (2007).","journal-title":"Diabetologia"},{"key":"1261_CR49","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/09513590.2019.1566451","volume":"35","author":"K Subramaniam","year":"2019","unstructured":"Subramaniam, K., Tripathi, A. & Dabadghao, P. Familial clustering of metabolic phenotype in brothers of women with polycystic ovary syndrome. Gynecol. Endocrinol. 35, 601\u2013603 (2019).","journal-title":"Gynecol. Endocrinol."},{"key":"1261_CR50","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/humrep\/dez104","volume":"34","author":"S Karthik","year":"2019","unstructured":"Karthik, S. et al. Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome. Hum. Reprod. 34, 1559\u20131566 (2019).","journal-title":"Hum. Reprod."},{"key":"1261_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00352","volume":"8","author":"L Lambertini","year":"2017","unstructured":"Lambertini, L. et al. Intrauterine reprogramming of the polycystic ovary syndrome: evidence from a pilot study of cord blood global methylation analysis. Front. Endocrinol. 8, 352 (2017).","journal-title":"Front. Endocrinol."},{"key":"1261_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-025-00769-1","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Transgenerational inheritance of diabetes susceptibility in male offspring with maternal androgen exposure. Cell Discov. 11, 14 (2025).","journal-title":"Cell Discov."},{"key":"1261_CR53","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2025.01.014","volume":"37","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Caloric restriction prevents inheritance of polycystic ovary syndrome through oocyte-mediated DNA methylation reprogramming. Cell Metab. 37, 920\u2013935 (2025).","journal-title":"Cell Metab."},{"key":"1261_CR54","doi-asserted-by":"publisher","first-page":"e4275","DOI":"10.1210\/clinem\/dgab422","volume":"106","author":"A Abbara","year":"2021","unstructured":"Abbara, A. & Dhillo, W. S. Targeting elevated GnRH pulsatility to treat polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 106, e4275\u2013e4277 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR55","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/cen.14704","volume":"97","author":"A Garg","year":"2022","unstructured":"Garg, A., Patel, B., Abbara, A. & Dhillo, W. S. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS). Clin. Endocrinol. 97, 156\u2013164 (2022).","journal-title":"Clin. Endocrinol."},{"key":"1261_CR56","first-page":"1158","volume":"79","author":"C Gilling-Smith","year":"1994","unstructured":"Gilling-Smith, C., Willis, D. S., Beard, R. W. & Franks, S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 79, 1158\u20131165 (1994).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","volume":"47","author":"C Gilling-Smith","year":"1997","unstructured":"Gilling-Smith, C., Story, H., Rogers, V. & Franks, S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin. Endocrinol. 47, 93\u201399 (1997).","journal-title":"Clin. Endocrinol."},{"key":"1261_CR58","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1210\/en.2019-00428","volume":"160","author":"A Ruddenklau","year":"2019","unstructured":"Ruddenklau, A. & Campbell, R. E. Neuroendocrine impairments of polycystic ovary syndrome. Endocrinology 160, 2230\u20132242 (2019).","journal-title":"Endocrinology"},{"key":"1261_CR59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly, D. et al. Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum. Reprod. Update 22, 709\u2013724 (2016).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00641","volume":"11","author":"D Dewailly","year":"2020","unstructured":"Dewailly, D., Barbotin, A. L., Dumont, A., Catteau-Jonard, S. & Robin, G. Role of anti-M\u00fcllerian hormone in the pathogenesis of polycystic ovary syndrome. Front. Endocrinol. 11, 641 (2020).","journal-title":"Front. Endocrinol."},{"key":"1261_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10055","volume":"7","author":"I Cimino","year":"2016","unstructured":"Cimino, I. et al. Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat. Commun. 7, 10055 (2016).","journal-title":"Nat. Commun."},{"key":"1261_CR62","first-page":"2001","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler, J. E. et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab. 83, 2001\u20132005 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR63","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1210\/en.2013-1764","volume":"155","author":"P Wang","year":"2014","unstructured":"Wang, P. et al. Hypomethylation of the LH\/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome. Endocrinology 155, 1445\u20131452 (2014).","journal-title":"Endocrinology"},{"key":"1261_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao, H., Zhang, J., Cheng, X., Nie, X. & He, B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J. Ovarian Res. 16, 9 (2023).","journal-title":"J. Ovarian Res."},{"key":"1261_CR65","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41366-019-0318-z","volume":"43","author":"E Koivuaho","year":"2019","unstructured":"Koivuaho, E. et al. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS. Int. J. Obes. 43, 1370\u20131379 (2019).","journal-title":"Int. J. Obes."},{"key":"1261_CR66","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1210\/jc.2015-3543","volume":"101","author":"MM Ollila","year":"2016","unstructured":"Ollila, M. M. et al. Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study. J. Clin. Endocrinol. Metab. 101, 739\u2013747 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR67","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1210\/jc.2010-1290","volume":"96","author":"L Manner\u00e5s-Holm","year":"2011","unstructured":"Manner\u00e5s-Holm, L. et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J. Clin. Endocrinol. Metab. 96, E304\u2013E311 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR68","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87592","volume":"12","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin, E. et al. Proteomic analysis shows decreased type I fibers and ectopic fat accumulation in skeletal muscle from women with PCOS. Elife 12, RP87592 (2024).","journal-title":"Elife"},{"key":"1261_CR69","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.cmet.2025.08.002","volume":"37","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Chen, Z. J. & Zhao, H. Polycystic ovary syndrome: a metabolic disorder with therapeutic opportunities. Cell Metab. 37, 1932\u20131949 (2025).","journal-title":"Cell Metab."},{"key":"1261_CR70","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgad356","volume":"109","author":"F Bril","year":"2023","unstructured":"Bril, F. et al. Adipose tissue dysfunction in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 109, 10\u201324 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246200","volume":"16","author":"T Raeisi","year":"2021","unstructured":"Raeisi, T. et al. Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. PLoS ONE 16, e0246200 (2021).","journal-title":"PLoS ONE"},{"key":"1261_CR72","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis, E. & Dunaif, A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981\u20131030 (2012).","journal-title":"Endocr. Rev."},{"key":"1261_CR73","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.steroids.2013.05.001","volume":"78","author":"G Chazenbalk","year":"2013","unstructured":"Chazenbalk, G. et al. Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation. Steroids 78, 920\u2013926 (2013).","journal-title":"Steroids"},{"key":"1261_CR74","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1210\/jc.2017-00947","volume":"102","author":"MW O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly, M. W. et al. AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 102, 3327\u20133339 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR75","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","volume":"24","author":"NS Kakoly","year":"2018","unstructured":"Kakoly, N. S. et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum. Reprod. Update 24, 455\u2013467 (2018).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR76","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1210\/jc.2007-2117","volume":"93","author":"TM Barber","year":"2008","unstructured":"Barber, T. M. et al. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 93, 999\u20131004 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR77","doi-asserted-by":"publisher","first-page":"e2408","DOI":"10.1210\/clinem\/dgaa235","volume":"105","author":"U Ezeh","year":"2020","unstructured":"Ezeh, U., Chen, I. Y., Chen, Y. H. & Azziz, R. Adipocyte insulin resistance in PCOS: relationship with GLUT-4 expression and whole-body glucose disposal and \u03b2-cell function. J. Clin. Endocrinol. Metab. 105, e2408\u2013e2420 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR78","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.rbmo.2020.12.006","volume":"42","author":"SN Sendur","year":"2021","unstructured":"Sendur, S. N. & Yildiz, B. O. Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review. Reprod. Biomed. Online 42, 799\u2013818 (2021).","journal-title":"Reprod. Biomed. Online"},{"key":"1261_CR79","doi-asserted-by":"publisher","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","volume":"106","author":"TR Berni","year":"2021","unstructured":"Berni, T. R., Morgan, C. L. & Rees, D. A. Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study. J. Clin. Endocrinol. Metab. 106, e3369\u2013e3380 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR80","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ejendo\/lvad077","volume":"189","author":"MM Ollila","year":"2023","unstructured":"Ollila, M. M. et al. Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study. Eur. J. Endocrinol. 189, 96\u2013105 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"1261_CR81","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2337\/db20-0800","volume":"70","author":"T Zhu","year":"2021","unstructured":"Zhu, T., Cui, J. & Goodarzi, M. O. Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke. Diabetes 70, 627\u2013637 (2021).","journal-title":"Diabetes"},{"key":"1261_CR82","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/humrep\/deab239","volume":"37","author":"MA Awoke","year":"2021","unstructured":"Awoke, M. A. et al. Weight gain and lifestyle factors in women with and without polycystic ovary syndrome. Hum. Reprod. 37, 129\u2013141 (2021).","journal-title":"Hum. Reprod."},{"key":"1261_CR83","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim, S. S., Davies, M. J., Norman, R. J. & Moran, L. J. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 18, 618\u2013637 (2012).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR84","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/humrep\/dead053","volume":"38","author":"LJ Dobbie","year":"2023","unstructured":"Dobbie, L. J. et al. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a mendelian randomization study with meta-analysis. Hum. Reprod. 38, 1168\u20131182 (2023).","journal-title":"Hum. Reprod."},{"key":"1261_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052734","volume":"22","author":"S Aboeldalyl","year":"2021","unstructured":"Aboeldalyl, S. et al. The role of chronic inflammation in polycystic ovarian syndrome \u2014 a systematic review and meta-analysis. Int. J. Mol. Sci. 22, 2734 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1261_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401772","volume":"11","author":"S Torstensson","year":"2024","unstructured":"Torstensson, S. et al. Androgens modulate the immune profile in a mouse model of polycystic ovary syndrome. Adv. Sci. 11, e2401772 (2024).","journal-title":"Adv. Sci."},{"key":"1261_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.993619","volume":"13","author":"ACH Neven","year":"2022","unstructured":"Neven, A. C. H., Mousa, A., Boyle, J. A. & Teede, H. J. Endocrine and metabolic interactions in healthy pregnancies and hyperinsulinemic pregnancies affected by polycystic ovary syndrome, diabetes and obesity. Front. Endocrinol. 13, 993619 (2022).","journal-title":"Front. Endocrinol."},{"key":"1261_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01337-0","volume":"22","author":"H Yan","year":"2024","unstructured":"Yan, H. et al. Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies. Reprod. Biol. Endocrinol. 22, 159 (2024).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1261_CR89","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","volume":"27","author":"S Palomba","year":"2021","unstructured":"Palomba, S., Piltonen, T. T. & Giudice, L. C. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum. Reprod. Update 27, 584\u2013618 (2021).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR90","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1038\/s41591-025-03592-z","volume":"31","author":"G Eriksson","year":"2025","unstructured":"Eriksson, G. et al. Single-cell profiling of the human endometrium in polycystic ovary syndrome. Nat. Med. 31, 1925\u20131938 (2025).","journal-title":"Nat. Med."},{"key":"1261_CR91","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1210\/jc.2013-1923","volume":"98","author":"TT Piltonen","year":"2013","unstructured":"Piltonen, T. T. et al. Mesenchymal stem\/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential. J. Clin. Endocrinol. Metab. 98, 3765\u20133775 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR92","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jama.2021.23769","volume":"327","author":"HG Huddleston","year":"2022","unstructured":"Huddleston, H. G. & Dokras, A. Diagnosis and treatment of polycystic ovary syndrome. JAMA 327, 274\u2013275 (2022).","journal-title":"JAMA"},{"key":"1261_CR93","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/jcmm.16205","volume":"25","author":"W Ye","year":"2021","unstructured":"Ye, W., Xie, T., Song, Y. & Zhou, L. The role of androgen and its related signals in PCOS. J. Cell Mol. Med. 25, 1825\u20131837 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"1261_CR94","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jwh.2014.5000","volume":"24","author":"AE Joham","year":"2015","unstructured":"Joham, A. E., Teede, H. J., Ranasinha, S., Zoungas, S. & Boyle, J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J. Womens Health 24, 299\u2013307 (2015).","journal-title":"J. Womens Health"},{"key":"1261_CR95","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield, R. L. & Ehrmann, D. A. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 37, 467\u2013520 (2016).","journal-title":"Endocr. Rev."},{"key":"1261_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40991-z","volume":"13","author":"A Meltsov","year":"2023","unstructured":"Meltsov, A. et al. Targeted gene expression profiling for accurate endometrial receptivity testing. Sci. Rep. 13, 13959 (2023).","journal-title":"Sci. Rep."},{"key":"1261_CR97","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/humrep\/dez159","volume":"34","author":"S Persson","year":"2019","unstructured":"Persson, S. et al. Fecundity among women with polycystic ovary syndrome (PCOS)\u2014a population-based study. Hum. Reprod. 34, 2052\u20132060 (2019).","journal-title":"Hum. Reprod."},{"key":"1261_CR98","doi-asserted-by":"publisher","first-page":"545.e1","DOI":"10.1016\/j.ajog.2024.11.010","volume":"232","author":"M Forslund","year":"2025","unstructured":"Forslund, M. et al. Fertility and age at childbirth in polycystic ovary syndrome: results from a longitudinal population-based cohort study. Am. J. Obstet. Gynecol. 232, 545.e1\u2013545.e10 (2025).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1261_CR99","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/humrep\/deaa099","volume":"35","author":"G Mills","year":"2020","unstructured":"Mills, G., Badeghiesh, A., Suarthana, E., Baghlaf, H. & Dahan, M. H. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum. Reprod. 35, 1666\u20131674 (2020).","journal-title":"Hum. Reprod."},{"key":"1261_CR100","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/humrep\/deaa192","volume":"35","author":"X Chen","year":"2020","unstructured":"Chen, X., Kong, L., Piltonen, T. T., Gissler, M. & Lavebratt, C. Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study. Hum. Reprod. 35, 2336\u20132347 (2020).","journal-title":"Hum. Reprod."},{"key":"1261_CR101","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/ije\/dyy103","volume":"47","author":"AS Oberg","year":"2018","unstructured":"Oberg, A. S., VanderWeele, T. J., Almqvist, C. & Hernandez-Diaz, S. Pregnancy complications following fertility treatment \u2014 disentangling the role of multiple gestation. Int. J. Epidemiol. 47, 1333\u20131342 (2018).","journal-title":"Int. J. Epidemiol."},{"key":"1261_CR102","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/humupd\/dmv044","volume":"22","author":"S Vannuccini","year":"2016","unstructured":"Vannuccini, S. et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum. Reprod. Update 22, 104\u2013115 (2016).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR103","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/HYPERTENSIONAHA.118.12046","volume":"73","author":"F von Versen-H\u00f6ynck","year":"2019","unstructured":"von Versen-H\u00f6ynck, F. et al. Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy. Hypertension 73, 680\u2013690 (2019).","journal-title":"Hypertension"},{"key":"1261_CR104","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/humupd\/dmaf030","volume":"32","author":"ACH Neven","year":"2026","unstructured":"Neven, A. C. H. et al. Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis. Hum. Reprod. Update 32,\u00a0277\u2013312\u00a0(2026).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR105","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1093\/ejendo\/lvae125","volume":"191","author":"ACH Neven","year":"2024","unstructured":"Neven, A. C. H. et al. Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis. Eur. J. Endocrinol. 191, S15\u2013S27 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"1261_CR106","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.fertnstert.2023.01.031","volume":"119","author":"K VanHise","year":"2023","unstructured":"VanHise, K. et al. Racial and ethnic disparities in polycystic ovary syndrome. Fertil. Steril. 119, 348\u2013354 (2023).","journal-title":"Fertil. Steril."},{"key":"1261_CR107","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s12603-023-2025-7","volume":"27","author":"L Lengel\u00e9","year":"2023","unstructured":"Lengel\u00e9, L., Grande de Fran\u00e7a, N. A., Rolland, Y., Guyonnet, S. & de Souto Barreto, P. Body composition, physical function, and dietary patterns in people from 20 to over 80 years old. J. Nutr. Health Aging 27, 1047\u20131055 (2023).","journal-title":"J. Nutr. Health Aging"},{"key":"1261_CR108","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41591-025-03984-1","volume":"31","author":"X Gao","year":"2025","unstructured":"Gao, X. et al. Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes. Nat. Med. 31, 4214\u20134224 (2025).","journal-title":"Nat. Med."},{"key":"1261_CR109","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.bpobgyn.2013.08.001","volume":"27","author":"EK Tan","year":"2013","unstructured":"Tan, E. K. & Tan, E. L. Alterations in physiology and anatomy during pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 27, 791\u2013802 (2013).","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"1261_CR110","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.rbmo.2013.03.009","volume":"27","author":"EA Kuijper","year":"2013","unstructured":"Kuijper, E. A., Ket, J. C., Caanen, M. R. & Lambalk, C. B. Reproductive hormone concentrations in pregnancy and neonates: a systematic review. Reprod. Biomed. Online 27, 33\u201363 (2013).","journal-title":"Reprod. Biomed. Online"},{"key":"1261_CR111","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8315519","volume":"2022","author":"J Huang","year":"2022","unstructured":"Huang, J., Liu, Y., Yang, H., Xu, Y. & Lv, W. The effect of serum \u03b2-human chorionic gonadotropin on pregnancy complications and adverse pregnancy outcomes: a systematic review and meta-analysis. Comput. Math. Methods Med. 2022, 8315519 (2022).","journal-title":"Comput. Math. Methods Med."},{"key":"1261_CR112","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/FM9.0000000000000037","volume":"2","author":"MY Li","year":"2020","unstructured":"Li, M. Y. et al. Sex hormone-binding globulin, cardiometabolic biomarkers, and gestational diabetes: a longitudinal study and meta-analysis. Matern. Fetal Med. 2, 2\u20139 (2020).","journal-title":"Matern. Fetal Med."},{"key":"1261_CR113","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/JOE-21-0332","volume":"253","author":"A Hufnagel","year":"2022","unstructured":"Hufnagel, A., Dearden, L., Fernandez-Twinn, D. S. & Ozanne, S. E. Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia. J. Endocrinol. 253, R47\u2013R63 (2022).","journal-title":"J. Endocrinol."},{"key":"1261_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-11-60","volume":"11","author":"A K\u00f6ninger","year":"2013","unstructured":"K\u00f6ninger, A. et al. Anti-Mullerian-hormone levels during pregnancy and postpartum. Reprod. Biol. Endocrinol. 11, 60 (2013).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1261_CR115","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.fertnstert.2020.06.015","volume":"115","author":"A Kaing","year":"2021","unstructured":"Kaing, A. et al. Highly elevated level of antim\u00fcllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction. Fertil. Steril. 115, 438\u2013446 (2021).","journal-title":"Fertil. Steril."},{"key":"1261_CR116","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1515\/hmbci-2015-0025","volume":"26","author":"E Herrera","year":"2016","unstructured":"Herrera, E. & Desoye, G. Maternal and fetal lipid metabolism under normal and gestational diabetic conditions. Horm. Mol. Biol. Clin. Investig. 26, 109\u2013127 (2016).","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"1261_CR117","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.preghy.2017.12.003","volume":"11","author":"J Wan","year":"2018","unstructured":"Wan, J. et al. The reduction in circulating levels of estrogen and progesterone in women with preeclampsia. Pregnancy Hypertens. 11, 18\u201325 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"1261_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1128-1","volume":"16","author":"RF Goldstein","year":"2018","unstructured":"Goldstein, R. F. et al. Gestational weight gain across continents and ethnicity: systematic review and meta-analysis of maternal and infant outcomes in more than one million women. BMC Med. 16, 153 (2018).","journal-title":"BMC Med."},{"key":"1261_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00253","volume":"5","author":"P Chatterjee","year":"2014","unstructured":"Chatterjee, P., Chiasson, V. L., Bounds, K. R. & Mitchell, B. M. Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy. Front. Immunol. 5, 253 (2014).","journal-title":"Front. Immunol."},{"key":"1261_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.752660","volume":"12","author":"AH Jarmund","year":"2021","unstructured":"Jarmund, A. H. et al. Cytokine patterns in maternal serum from first trimester to term and beyond. Front. Immunol. 12, 752660 (2021).","journal-title":"Front. Immunol."},{"key":"1261_CR121","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ando.2016.04.023","volume":"77","author":"Y Morel","year":"2016","unstructured":"Morel, Y. et al. Evolution of steroids during pregnancy: maternal, placental and fetal synthesis. Ann. Endocrinol. 77, 82\u201389 (2016).","journal-title":"Ann. Endocrinol."},{"key":"1261_CR122","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/837901","volume":"2012","author":"J Kaludjerovic","year":"2012","unstructured":"Kaludjerovic, J. & Ward, W. E. The interplay between estrogen and fetal adrenal cortex. J. Nutr. Metab. 2012, 837901 (2012).","journal-title":"J. Nutr. Metab."},{"key":"1261_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13024","volume":"9","author":"Q Xia","year":"2023","unstructured":"Xia, Q. et al. Elevated baseline LH\/FSH ratio is associated with poor ovulatory response but better clinical pregnancy and live birth in Chinese women with PCOS after ovulation induction. Heliyon 9, e13024 (2023).","journal-title":"Heliyon"},{"key":"1261_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00862-6","volume":"19","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Liu, B., Wu, G. & Yang, J. Exploration of the value of progesterone and progesterone\/estradiol ratio on the hCG trigger day in predicting pregnancy outcomes of PCOS patients undergoing IVF\/ICSI: a retrospective cohort study. Reprod. Biol. Endocrinol. 19, 184 (2021).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1261_CR125","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/cells10020459","volume":"10","author":"XL Xu","year":"2021","unstructured":"Xu, X. L., Deng, S. L., Lian, Z. X. & Yu, K. Estrogen receptors in polycystic ovary syndrome. Cells 10, 459 (2021).","journal-title":"Cells"},{"key":"1261_CR126","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1210\/jc.2015-3803","volume":"101","author":"M Hulchiy","year":"2016","unstructured":"Hulchiy, M., Nybacka, \u00c5, Sahlin, L. & Hirschberg, A. L. Endometrial expression of estrogen receptors and the androgen receptor in women with polycystic ovary syndrome: a lifestyle intervention study. J. Clin. Endocrinol. Metab. 101, 561\u2013571 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR127","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bpobgyn.2016.03.008","volume":"37","author":"TT Piltonen","year":"2016","unstructured":"Piltonen, T. T. Polycystic ovary syndrome: endometrial markers. Best. Pract. Res. Clin. Obstet. Gynaecol. 37, 66\u201379 (2016).","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"1261_CR128","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/humupd\/dmae006","volume":"30","author":"E Derisoud","year":"2024","unstructured":"Derisoud, E., Jiang, H., Zhao, A., Chavatte-Palmer, P. & Deng, Q. Revealing the molecular landscape of human placenta: a systematic review and meta-analysis of single-cell RNA sequencing studies. Hum. Reprod. Update 30, 410\u2013441 (2024).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu3699","volume":"11","author":"L Luyckx","year":"2025","unstructured":"Luyckx, L. et al. Prenatally androgenized PCOS mice have ovary-independent uterine dysfunction and placental inflammation aggravated by high-fat diet. Sci. Adv. 11, eadu3699 (2025).","journal-title":"Sci. Adv."},{"key":"1261_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309429","volume":"11","author":"H Lu","year":"2024","unstructured":"Lu, H. et al. Dissecting the impact of maternal androgen exposure on developmental programming through targeting the androgen receptor. Adv. Sci. 11, e2309429 (2024).","journal-title":"Adv. Sci."},{"key":"1261_CR131","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.rbmo.2020.09.019","volume":"42","author":"R Valdimarsdottir","year":"2021","unstructured":"Valdimarsdottir, R. et al. Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels. Reprod. BioMed. Online 42, 217\u2013225 (2021).","journal-title":"Reprod. BioMed. Online"},{"key":"1261_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-3-23","volume":"3","author":"A Falbo","year":"2010","unstructured":"Falbo, A. et al. Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes. J. Ovarian Res. 3, 23 (2010).","journal-title":"J. Ovarian Res."},{"key":"1261_CR133","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/1471-0528.12558","volume":"121","author":"KV Naver","year":"2014","unstructured":"Naver, K. V. et al. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. BJOG 121, 575\u2013581 (2014).","journal-title":"BJOG"},{"key":"1261_CR134","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.fertnstert.2017.06.015","volume":"108","author":"MA de Wilde","year":"2017","unstructured":"de Wilde, M. A. et al. Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype. Fertil. Steril. 108, 333\u2013340 (2017).","journal-title":"Fertil. Steril."},{"key":"1261_CR135","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/IJWH.S465541","volume":"16","author":"S Wang","year":"2024","unstructured":"Wang, S., Tan, J., Wang, C., Huang, J. & Zhou, C. Free androgen index might not be a perfect predictor of infertility outcomes in patients with polycystic ovary syndrome undergoing frozen embryo transfer:a retrospective cohort study. Int. J. Womens Health 16, 1349\u20131359 (2024).","journal-title":"Int. J. Womens Health"},{"key":"1261_CR136","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.fertnstert.2017.12.023","volume":"109","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment. Fertil. Steril. 109, 720\u2013727 (2018).","journal-title":"Fertil. Steril."},{"key":"1261_CR137","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/humrep\/deac210","volume":"37","author":"LV Farland","year":"2022","unstructured":"Farland, L. V. et al. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts. Hum. Reprod. 37, 2690\u20132699 (2022).","journal-title":"Hum. Reprod."},{"key":"1261_CR138","first-page":"1","volume":"73","author":"K Lewandowski","year":"2022","unstructured":"Lewandowski, K. et al. High prevalence of early (1st trimester) gestational diabetes mellitus in Polish women is accompanied by marked insulin resistance \u2014 comparison to PCOS model. Endokrynol. Pol. 73, 1\u20137 (2022).","journal-title":"Endokrynol. Pol."},{"key":"1261_CR139","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/humrep\/deq272","volume":"25","author":"SM Veltman-Verhulst","year":"2010","unstructured":"Veltman-Verhulst, S. M. et al. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Hum. Reprod. 25, 3123\u20133128 (2010).","journal-title":"Hum. Reprod."},{"key":"1261_CR140","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000067719","volume":"54","author":"S Bjercke","year":"2002","unstructured":"Bjercke, S. et al. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol. Obstet. Invest. 54, 94\u201398 (2002).","journal-title":"Gynecol. Obstet. Invest."},{"key":"1261_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.638727","volume":"12","author":"I Diboun","year":"2021","unstructured":"Diboun, I. et al. Metabolomic profiling of pregnancies with polycystic ovary syndrome identifies a unique metabolic signature and potential predictive biomarkers of low birth weight. Front. Endocrinol. 12, 638727 (2021).","journal-title":"Front. Endocrinol."},{"key":"1261_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176358","volume":"21","author":"B Lair","year":"2020","unstructured":"Lair, B., Laurens, C., Van Den Bosch, B. & Moro, C. Novel insights and mechanisms of lipotoxicity-driven insulin resistance. Int. J. Mol. Sci. 21, 6358 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1261_CR143","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","volume":"45","author":"SA Summers","year":"2006","unstructured":"Summers, S. A. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45, 42\u201372 (2006).","journal-title":"Prog. Lipid Res."},{"key":"1261_CR144","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000923","volume":"8","author":"J Abbade","year":"2020","unstructured":"Abbade, J. et al. Increased placental mitochondrial fusion in gestational diabetes mellitus: an adaptive mechanism to optimize feto-placental metabolic homeostasis? BMJ Open Diabetes Res. Care 8, e000923 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1261_CR145","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1159\/000453174","volume":"40","author":"AU Blachnio-Zabielska","year":"2016","unstructured":"Blachnio-Zabielska, A. U., Chacinska, M., Vendelbo, M. H. & Zabielski, P. The crucial role of c18-cer in fat-induced skeletal muscle insulin resistance. Cell. Physiol. Biochem. 40, 1207\u20131220 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"1261_CR146","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","volume":"21","author":"S Palomba","year":"2015","unstructured":"Palomba, S. et al. Pregnancy complications in women with polycystic ovary syndrome. Hum. Reprod. Update 21, 575\u2013592 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR147","first-page":"174","volume":"3","author":"MH Kangasniemi","year":"2022","unstructured":"Kangasniemi, M. H. et al. Artificial intelligence deep learning model assessment of leukocyte counts and proliferation in endometrium from women with and without polycystic ovary syndrome. F. S. Sci. 3, 174\u2013186 (2022).","journal-title":"F. S. Sci."},{"key":"1261_CR148","doi-asserted-by":"crossref","unstructured":"Piltonen, T. T. in How to Prepare the Endometrium to Maximize Implantation Rates and IVF Success (eds Kovacs, G. & Salamonsen, L.) 187\u2013196 (Cambridge Univ. Press, 2019).","DOI":"10.1017\/9781108236263.022"},{"key":"1261_CR149","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/clinem\/dgab684","volume":"107","author":"LMT Stokkeland","year":"2022","unstructured":"Stokkeland, L. M. T. et al. Changes in serum cytokines throughout pregnancy in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 107, 39\u201352 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR150","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1210\/jc.2014-1214","volume":"99","author":"S Palomba","year":"2014","unstructured":"Palomba, S. et al. Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study. J. Clin. Endocrinol. Metab. 99, 2942\u20132951 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254895","volume":"16","author":"SL Fougner","year":"2021","unstructured":"Fougner, S. L., Vanky, E., L\u00f8vvik, T. S. & Carlsen, S. M. No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used. PLoS ONE 16, e0254895 (2021).","journal-title":"PLoS ONE"},{"key":"1261_CR152","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.30543","volume":"7","author":"MSA Talmo","year":"2024","unstructured":"Talmo, M. S. A. et al. Growth restriction in the offspring of mothers with polycystic ovary syndrome. JAMA Netw. Open 7, e2430543 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1261_CR153","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1111\/1471-0528.16890","volume":"128","author":"H Valgeirsdottir","year":"2021","unstructured":"Valgeirsdottir, H. et al. Polycystic ovary syndrome and risk of stillbirth: a nationwide register-based study. BJOG 128, 2073\u20132082 (2021).","journal-title":"BJOG"},{"key":"1261_CR154","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/humupd\/dml036","volume":"12","author":"CM Boomsma","year":"2006","unstructured":"Boomsma, C. M. et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum. Reprod. Update 12, 673\u2013683 (2006).","journal-title":"Hum. Reprod. Update"},{"key":"1261_CR155","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004863","volume":"95","author":"HF Yu","year":"2016","unstructured":"Yu, H. F., Chen, H. S., Rao, D. P. & Gong, J. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine 95, e4863 (2016).","journal-title":"Medicine"},{"key":"1261_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-11-56","volume":"11","author":"JZ Qin","year":"2013","unstructured":"Qin, J. Z. et al. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod. Biol. Endocrinol. 11, 56 (2013).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1261_CR157","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/humrep\/deac154","volume":"37","author":"SQ Wei","year":"2022","unstructured":"Wei, S. Q., Bilodeau-Bertrand, M. & Auger, N. Association of PCOS with offspring morbidity: a longitudinal cohort study. Hum. Reprod. 37, 2135\u20132142 (2022).","journal-title":"Hum. Reprod."},{"key":"1261_CR158","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1097\/AOG.0000000000000852","volume":"125","author":"DA Doherty","year":"2015","unstructured":"Doherty, D. A., Newnham, J. P., Bower, C. & Hart, R. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet. Gynecol. 125, 1397\u20131406 (2015).","journal-title":"Obstet. Gynecol."},{"key":"1261_CR159","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10654-021-00756-2","volume":"36","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. Maternal hypertensive disorders and neurodevelopmental disorders in offspring: a population-based cohort in two nordic countries. Eur. J. Epidemiol. 36, 519\u2013530 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"1261_CR160","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/s41380-019-0398-0","volume":"24","author":"M Katsigianni","year":"2019","unstructured":"Katsigianni, M., Karageorgiou, V., Lambrinoudaki, I. & Siristatidis, C. Maternal polycystic ovarian syndrome in autism spectrum disorder: a systematic review and meta-analysis. Mol. Psychiatry 24, 1787\u20131797 (2019).","journal-title":"Mol. Psychiatry"},{"key":"1261_CR161","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1056\/NEJMoa042275","volume":"351","author":"PL Hofman","year":"2004","unstructured":"Hofman, P. L. et al. Premature birth and later insulin resistance. N. Engl. J. Med. 351, 2179\u20132186 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1261_CR162","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa067187","volume":"356","author":"P Hovi","year":"2007","unstructured":"Hovi, P. et al. Glucose regulation in young adults with very low birth weight. N. Engl. J. Med. 356, 2053\u20132063 (2007).","journal-title":"N. Engl. J. Med."},{"key":"1261_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6080076","volume":"6","author":"R Neiger","year":"2017","unstructured":"Neiger, R. Long-term effects of pregnancy complications on maternal health: a review. J. Clin. Med. 6, 76 (2017).","journal-title":"J. Clin. Med."},{"key":"1261_CR164","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e111","volume":"38","author":"KJ Ryu","year":"2023","unstructured":"Ryu, K. J. et al. Maternal polycystic ovary syndrome and the risk of early childhood obesity in female offspring: a nationwide population-based study. J. Korean Med. Sci. 38, e111 (2023).","journal-title":"J. Korean Med. Sci."},{"key":"1261_CR165","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10815-021-02378-9","volume":"39","author":"F Zhang","year":"2022","unstructured":"Zhang, F., Ying, L., Zhang, Q., Wang, F. & Qu, F. Association between maternal polycystic ovary syndrome and early childhood growth: a continuous observation from 3 months to 6 years of age. J. Assist. Reprod. Genet. 39, 461\u2013471 (2022).","journal-title":"J. Assist. Reprod. Genet."},{"key":"1261_CR166","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/humrep\/deab112","volume":"36","author":"X Chen","year":"2021","unstructured":"Chen, X., Koivuaho, E., Piltonen, T. T., Gissler, M. & Lavebratt, C. Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study. Hum. Reprod. 36, 2345\u20132357 (2021).","journal-title":"Hum. Reprod."},{"key":"1261_CR167","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.diabet.2014.02.003","volume":"40","author":"A Chavey","year":"2014","unstructured":"Chavey, A., Ah Kioon, M. D., Bailb\u00e9, D., Movassat, J. & Portha, B. Maternal diabetes, programming of beta-cell disorders and intergenerational risk of type 2 diabetes. Diabetes Metab. 40, 323\u2013330 (2014).","journal-title":"Diabetes Metab."},{"key":"1261_CR168","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/aogs.12850","volume":"95","author":"AE Joham","year":"2016","unstructured":"Joham, A. E. et al. Obesity, polycystic ovary syndrome and breastfeeding: an observational study. Acta Obstet. Gynecol. Scand. 95, 458\u2013466 (2016).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"1261_CR169","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/aogs.14868","volume":"103","author":"K Rassie","year":"2024","unstructured":"Rassie, K., Dhungana, R. R., Mousa, A., Teede, H. & Joham, A. E. Maternal metabolic conditions as predictors of breastfeeding outcomes: insights from an Australian cohort study. Acta Obstet. Gynecol. Scand. 103, 1570\u20131583 (2024).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"1261_CR170","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13006-026-00843-8","volume":"21","author":"AE Husby","year":"2026","unstructured":"Husby, A. E., Simpson, M. R., Dalbye, R., L\u00f8vvik, T. S. & Vanky, E. Exclusive breastfeeding among women with polycystic ovary syndrome versus women from a population-based cohort: a cohort study. Int. Breastfeed. J. 21,\u00a054 (2026).","journal-title":"Int. Breastfeed. J."},{"key":"1261_CR171","doi-asserted-by":"publisher","DOI":"10.11606\/S1518-8787.2018052000742","volume":"52","author":"DS Prado","year":"2018","unstructured":"Prado, D. S. et al. The influence of mode of delivery on neonatal and maternal short and long-term outcomes. Rev. Saude Publica 52, 95 (2018).","journal-title":"Rev. Saude Publica"},{"key":"1261_CR172","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1010539515624964","volume":"28","author":"C Binns","year":"2016","unstructured":"Binns, C., Lee, M. & Low, W. Y. The long-term public health benefits of breastfeeding. Asia Pac. J. Public. Health 28, 7\u201314 (2016).","journal-title":"Asia Pac. J. Public. Health"},{"key":"1261_CR173","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.rbmo.2021.05.008","volume":"43","author":"ALP Dietz de Loos","year":"2021","unstructured":"Dietz de Loos, A. L. P. et al. Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention. Reprod. Biomed. Online 43, 298\u2013309 (2021).","journal-title":"Reprod. Biomed. Online"},{"key":"1261_CR174","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/02701367.2019.1639601","volume":"90","author":"F Charkamyani","year":"2019","unstructured":"Charkamyani, F., Hosseinkhani, A., Neisani Samani, L. & Khedmat, L. Reducing the adverse maternal and fetal outcomes in IVF women by exercise interventions during pregnancy. Res. Q. Exerc. Sport. 90, 589\u2013599 (2019).","journal-title":"Res. Q. Exerc. Sport."},{"key":"1261_CR175","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192670","volume":"13","author":"AM van Oers","year":"2018","unstructured":"van Oers, A. M. et al. Association between periconceptional weight loss and maternal and neonatal outcomes in obese infertile women. PLoS ONE 13, e0192670 (2018).","journal-title":"PLoS ONE"},{"key":"1261_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2023.103587","volume":"48","author":"\u00c5 Magnusson","year":"2024","unstructured":"Magnusson, \u00c5 et al. Endometrial preparation protocols prior to frozen embryo transfer \u2014 convenience or safety? Reprod. Biomed. Online 48, 103587 (2024).","journal-title":"Reprod. Biomed. Online"},{"key":"1261_CR177","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1210\/jc.2011-3061","volume":"97","author":"L Morin-Papunen","year":"2012","unstructured":"Morin-Papunen, L. et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J. Clin. Endocrinol. Metab. 97, 1492\u20131500 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR178","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/humrep\/der154","volume":"26","author":"SB Kj\u00f8tr\u00f8d","year":"2011","unstructured":"Kj\u00f8tr\u00f8d, S. B. et al. Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study. Hum. Reprod. 26, 2045\u20132053 (2011).","journal-title":"Hum. Reprod."},{"key":"1261_CR179","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2025.13668","volume":"334","author":"AWT van der Wel","year":"2025","unstructured":"van der Wel, A. W. T. et al. Myo-inositol supplementation to prevent pregnancy complications in polycystic ovary syndrome: a randomized clinical trial. JAMA 334, 1151\u20131159 (2025).","journal-title":"JAMA"},{"key":"1261_CR180","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-083550","volume":"14","author":"K Dao","year":"2024","unstructured":"Dao, K. et al. Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six teratology information services. BMJ Open 14, e083550 (2024).","journal-title":"BMJ Open"},{"key":"1261_CR181","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deae108.041","volume":"39","author":"K Hviid","year":"2024","unstructured":"Hviid, K. et al. P-779 GLP-1 receptor agonist treatment in early pregnancy and risk of pregnancy complications \u2014 a nationwide cohort study. Hum. Reprod. 39, deae108.041 (2024).","journal-title":"Hum. Reprod."},{"key":"1261_CR182","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1001\/jama.2025.20951","volume":"334","author":"J Maya","year":"2025","unstructured":"Maya, J. et al. Gestational weight gain and pregnancy outcomes after GLP-1 receptor agonist discontinuation. JAMA 334, 2186\u20132196 (2025).","journal-title":"JAMA"},{"key":"1261_CR183","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13737","volume":"25","author":"JL Benham","year":"2024","unstructured":"Benham, J. L. et al. Impact of bariatric surgery on anthropometric, metabolic, and reproductive outcomes in polycystic ovary syndrome: a systematic review and meta-analysis. Obes. Rev. 25, e13737 (2024).","journal-title":"Obes. Rev."},{"key":"1261_CR184","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0140-6736(24)00538-5","volume":"403","author":"SNS Samarasinghe","year":"2024","unstructured":"Samarasinghe, S. N. S. et al. Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial. Lancet 403, 2489\u20132503 (2024).","journal-title":"Lancet"},{"key":"1261_CR185","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1056\/NEJMoa1405789","volume":"372","author":"K Johansson","year":"2015","unstructured":"Johansson, K. et al. Outcomes of pregnancy after bariatric surgery. N. Engl. J. Med. 372, 814\u2013824 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1261_CR186","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bluher","year":"2019","unstructured":"Bluher, M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15, 288\u2013298 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1261_CR187","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S2213-8587(19)30026-9","volume":"7","author":"LM Jaacks","year":"2019","unstructured":"Jaacks, L. M. et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 7, 231\u2013240 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1261_CR188","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1016\/S2214-109X(23)00468-0","volume":"12","author":"JP Souza","year":"2024","unstructured":"Souza, J. P. et al. A global analysis of the determinants of maternal health and transitions in maternal mortality. Lancet Glob. Health 12, e306\u2013e316 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1261_CR189","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.amepre.2023.03.016","volume":"65","author":"KE Jackson","year":"2023","unstructured":"Jackson, K. E., Hamad, R., Karasek, D. & White, J. S. Sugar-sweetened beverage taxes and perinatal health: a quasi-experimental study. Am. J. Prev. Med. 65, 366\u2013376 (2023).","journal-title":"Am. J. Prev. Med."},{"key":"1261_CR190","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.30683","volume":"5","author":"M Lloyd","year":"2022","unstructured":"Lloyd, M., Teede, H., Bailey, C., Callander, E. & Ademi, Z. Projected return on investment from implementation of a lifestyle intervention to reduce adverse pregnancy outcomes. JAMA Netw. Open 5, e2230683 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1261_CR191","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/jamainternmed.2021.6373","volume":"182","author":"HJ Teede","year":"2022","unstructured":"Teede, H. J. et al. Association of antenatal diet and physical activity-based interventions with gestational weight gain and pregnancy outcomes: a systematic review and meta-analysis. JAMA Intern. Med. 182, 106\u2013114 (2022).","journal-title":"JAMA Intern. Med."},{"key":"1261_CR192","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1001\/jama.2021.4230","volume":"325","author":"AG Cantor","year":"2021","unstructured":"Cantor, A. G. et al. Counseling and behavioral interventions for healthy weight and weight gain in pregnancy: evidence report and systematic review for the US Preventive Services Task Force. JAMA 325, 2094\u20132109 (2021).","journal-title":"JAMA"},{"key":"1261_CR193","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","volume":"7","author":"TS Lovvik","year":"2019","unstructured":"Lovvik, T. S. et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 7, 256\u2013266 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1261_CR194","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-036981","volume":"10","author":"A Mousa","year":"2020","unstructured":"Mousa, A. et al. Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis. BMJ Open 10, e036981 (2020).","journal-title":"BMJ Open"},{"key":"1261_CR195","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgag098","author":"S Alesi","year":"2026","unstructured":"Alesi, S. et al. Early pregnancy biomarkers of inflammation and metabolic regulation in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. https:\/\/doi.org\/10.1210\/clinem\/dgag098 (2026).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1261_CR196","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/1471-0528.12631","volume":"121","author":"N Morisaki","year":"2014","unstructured":"Morisaki, N. et al. Risk factors for spontaneous and provider-initiated preterm delivery in high and low human development index countries: a secondary analysis of the world health organization multicountry survey on maternal and newborn health. BJOG 121, 101\u2013109 (2014).","journal-title":"BJOG"},{"key":"1261_CR197","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejogrb.2004.03.007","volume":"116","author":"J Valero de Bernab\u00e9","year":"2004","unstructured":"Valero de Bernab\u00e9, J. et al. Risk factors for low birth weight: a review. Eur. J. Obstet. Gynecol. Reprod. Biol. 116, 3\u201315 (2004).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1261_CR198","doi-asserted-by":"publisher","first-page":"280.e1","DOI":"10.1016\/j.ajog.2020.08.048","volume":"224","author":"S Alur-Gupta","year":"2021","unstructured":"Alur-Gupta, S., Boland, M. R., Barnhart, K. T., Sammel, M. D. & Dokras, A. Postpartum complications increased in women with polycystic ovary syndrome. Am. J. Obstet. Gynecol. 224, 280.e1\u2013280.e13 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1261_CR199","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122070","volume":"8","author":"CT Tay","year":"2019","unstructured":"Tay, C. T. et al. Perinatal mental health in women with polycystic ovary syndrome: a cross-sectional analysis of an Australian population-based cohort. J. Clin. Med. 8, 2070 (2019).","journal-title":"J. Clin. Med."},{"key":"1261_CR200","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik, D. L. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613\u2013622 (2017).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01261-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:01:53Z","timestamp":1786449713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-026-01261-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":200,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1038\/s41574-026-01261-w","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"14 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.J.T. is the primary investigator of the Australian National Health and Medical Research Council (NHMRC)-funded Centre for Research Excellence in Women\u2019s Health in Reproductive Life (CRE-WHiRL; APP#1171592) and is supported by an NHMRC Fellowship (APP#2009326). She is the president of the International Society of Endocrinology. T.T.P. is the president of the Androgen Excess and Polycystic Ovary Syndrome Society (AEPCOS). L.J.M. is the chief investigator of the CRE-WHiRL and is supported by a Veski Fellowship. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}